2015 has been a turbulent year for pharma stocks. Deals have helped the sector remain in favor, but concerns about pricing and the Valeant scandal are just two of the factors that have tarred the sector's reputation, bringing valuations back down to earth.
Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger
Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway.
Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK.
Rupert covers everything value investing for ValueWalk
he 10th Annual New York Value Investing Congress takes place in New York on September 8th and September 9th 2014. ValueWalk will be providing coverage of the event- below is... Read More
After getting a boost in early March, J.C. Penney Company, Inc. (NYSE:JCP)'s stock price has mostly been stuck in the mid-$8 range as analysts try to figure out whether... Read More
Prospect Of U.S. Fed Hike & its Effect On Asian Assets, Part I Gerald M. Hwang, CFA, Matthews Asia
How close are we to a U.S. Federal Reserve (Fed) rate... Read More
Finance Mythbuster: Is Economic Growth Good for Investors? by Wesley R. Gray, Ph.D., Alpha Architect  Author, Quantitative Value: A Practitioner’s Guide to Automating Intelligent Investment and Eliminating Behavioral Errors
Is Economic Growth... Read More
Former CalPers CEO Fred Buenrostro, one time investment chief at the US’s largest state pension fund, is admitting to a pay-for-play scandal and is implicating his one-time collaborator.
Former Calpers... Read More
If you have been following my blog postings, you are probably aware that I have an obsession with equity risk premiums (ERP), and have done an annual survey paper... Read More
Gold slid 23 percent this year, wiping $59.3 billion from the value of gold exchange-traded product holdings, after some investors lost faith in the metal as a store of... Read More
Mark Boyar presenting: "History Sure Does Rhyme" at the 8th Annual Value Investing Congress.
Mark Boyar of Boyar Value Group will be presenting: History Sure Does Rhyme at Value Investing... Read More
Will Passive Investors Become Taleb's Turkeys? by Alex Barrow, Macro Ops
Over a third and growing quickly. That’s the share of the market that’s now comprised of blind sheep passive... Read More
Despite a recent record distribution of capital, if GPs continue to find attractive exit routes, then high distribution levels are likely to continue for some time, notes Preqin.
Preqin in... Read More
